Cellect Biotechnology Ltd Sponsored ADR Aktie News

Tel Aviv , Oct. 15, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: “APOP”) (the “Company”), announced today the record date and distribution date for the contingent value rights (the “CVRs”) to be distributed in connection with the previously announced strategic merger with privately-held Quoin Pharmaceuticals, Inc., a specialty pharmaceutical company focused on rare and orphan di...

Cellect Biotechnology Ltd (NASDAQ: APOP) shareholders approved the previously announced strategic merger agreement with Quoin Pharmaceuticals, the company said in a press release on Monday. Shares of the Israel-headquartered firm jumped about 50% this morning.

Tel Aviv, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: "APOP"), announced shareholders voted to approve the previously announced strategic merger agreement with privately-held Quoin Pharmaceuticals, a specialty pharmaceutical company focused on rare and orphan diseases, and all other proposals presented at the Special General Meeting of shareholders held on September 2...

The stock price of Cellect Biotechnology Ltd (NASDAQ: APOP) increased by over 70% pre-market. This is why it happened.

Recruitment of Patient Provides Momentum to Commence Funding for the Technology under US Entity EnCellX Recruitment of Patient Provides Momentum to Commence Funding for the Technology under US Entity EnCellX

Strategic Merger Transaction Remains on Track to Close During the 2021 Third Quarter

The shares of Cellect Biotechnology Ltd (NASDAQ: APOP) increased by over 10% pre-market. This is why it happened.

Special General Meeting of Shareholders Scheduled for September 19, 2021